Literature DB >> 32203397

Exosomal α-synuclein as a biomarker for Parkinson disease.

Sarah Lemprière1.   

Abstract

Entities:  

Year:  2020        PMID： 32203397     DOI： 10.1038/s41582-020-0349-z

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.

Authors:  M Niu; Y Li; G Li; L Zhou; N Luo; M Yao; W Kang; J Liu
Journal:  Eur J Neurol       Date:  2020-04-13       Impact factor: 6.089
  1 in total
  6 in total

Review 1.  Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapy.

Authors:  Zainuddin Quadri; Ahmed Elsherbini; Erhard Bieberich
Journal:  Pharmacol Res       Date:  2021-12-02       Impact factor: 7.658

2.  Blood Exosomes Have Neuroprotective Effects in a Mouse Model of Parkinson's Disease.

Authors:  Ting Sun; Zhe-Xu Ding; Xin Luo; Qing-Shan Liu; Yong Cheng
Journal:  Oxid Med Cell Longev       Date:  2020-11-26       Impact factor: 6.543

Review 3.  Stem Cell-Derived Exosomes as Therapeutic Approach for Neurodegenerative Disorders: From Biology to Biotechnology.

Authors:  Rodrigo Pinheiro Araldi; Fernanda D'Amelio; Hugo Vigerelli; Thatiana Correa de Melo; Irina Kerkis
Journal:  Cells       Date:  2020-12-11       Impact factor: 6.600

Review 4.  Pathogenic and Potential Therapeutic Roles of Exosomes Derived From Immune Cells in Liver Diseases.

Authors:  Leyu Zhou; Mengyi Shen; Xiaoli Fan; Yifeng Liu; Li Yang
Journal:  Front Immunol       Date:  2022-02-04       Impact factor: 7.561

5.  Spatiotemporal modulations in heterotypic condensates of prion and α-synuclein control phase transitions and amyloid conversion.

Authors:  Aishwarya Agarwal; Lisha Arora; Sandeep K Rai; Anamika Avni; Samrat Mukhopadhyay
Journal:  Nat Commun       Date:  2022-03-03       Impact factor: 14.919

Review 6.  Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies.

Authors:  Pedro Magalhães; Hilal A Lashuel
Journal:  NPJ Parkinsons Dis       Date:  2022-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.